Xponance, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Xponance, Inc.
- $12.3 Billion
- Q3 2025
A detailed history of Xponance, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 3,151 shares of MIRM stock, worth $224,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,151Holding current value
$224,729% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
269Shares Held
57.5MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$373 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$197 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$188 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...